Saturday, October 4, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

We should consider testing Ozempic on healthy people

August 6, 2025
in Health News
Share on FacebookShare on Twitter


Mandatory Credit: Photo by Blondet Eliot/ABACA/Shutterstock (15320742p) This photo taken on May 26, 2025, during a ministerial visit to Novo Nordisk factory in Chartres, France, shows medicines (injection solution and injection pen for Ozempic, Wegovy, etc...) on the production line. Illustration - Novo Nordisk Factory - Chartres, France - 26 May 2025

Blondet Eliot/ABACA/Shutterstock

Author Mark Twain once noted that “life would be infinitely happier if we could only be born at the age of 80 and gradually approach 18”. The pursuit of youth has inspired legends and literature for centuries, but what if we are finally getting somewhere with it?

A recent study suggests that taking the GLP-1 drug Ozempic, whose active ingredient is semaglutide, could knock three years off people’s biological age. One place where this effect was most pronounced was the brain, which raises the possibility that drugs like Ozempic could help stave off conditions like dementia. It also seemed to de-age the inflammatory system, which is linked to health issues including heart disease, chronic pain, depression and more.

Semaglutide was developed for type 2 diabetes and has also transformed how we treat obesity. But it should be noted that its effects on ageing were seen specifically for those with a condition called HIV- associated lipohypertrophy, which causes excess fat and accelerated cellular ageing. Still, the study authors are confident the effects will apply to other people, too.

Ozempic seems to de-age the inflammatory system, which is linked to many conditions

It is tempting to think we should all now be taking these drugs to reap their age-reversing, disease-defying benefits. But without robust evidence from large, placebo-controlled trials in healthy people, we can’t be sure that’s a good idea. To carry these out would be controversial: there is a risk of side effects, so we would need to be confident the benefits outweigh this. And if supplies dwindle, priority should always go to those who are most in need.

Even so, many healthy people seem – at least anecdotally – to already be taking these drugs for weight loss “off label” without knowing if that is safe. Trials would give us a clearer picture of the risks of this, and tell us other things, like how rapid weight loss affects lean muscle mass.

As the list of health benefits of these drugs grows, perhaps it is now time to consider testing them in people without medical conditions, so we can finally see whether ageing can be slowed, and stop speculating about the elixir of youth.

Topics:



Source link : https://www.newscientist.com/article/mg26735552-700-we-should-consider-testing-ozempic-on-healthy-people/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

Author :

Publish date : 2025-08-06 18:00:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

Make the Diagnosis: It’s Not Just the Rash. This Patient Has Multiple Other Symptoms.

Next Post

Waist Size Proves Key to Assessing Liver Health

Related Posts

Health News

Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say

October 3, 2025
Health News

Ahead of Shutdown, Most Americans Said They Wanted ACA Tax Credits Extended

October 3, 2025
Health News

Medical Groups Call for Physician Exemptions to Trump’s Executive Order

October 3, 2025
Health News

Chronic Back Pain in Seniors May Ease With Acupuncture

October 3, 2025
Health News

Missed Mammogram Warning; NCI Chief Installed; ‘Father of Palliative Care’ Dies

October 3, 2025
Health News

FDA Approves Maintenance Combo for Small Cell Lung Cancer

October 3, 2025
Load More

Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say

October 3, 2025

Ahead of Shutdown, Most Americans Said They Wanted ACA Tax Credits Extended

October 3, 2025

Medical Groups Call for Physician Exemptions to Trump’s Executive Order

October 3, 2025

Chronic Back Pain in Seniors May Ease With Acupuncture

October 3, 2025

Missed Mammogram Warning; NCI Chief Installed; ‘Father of Palliative Care’ Dies

October 3, 2025

FDA Approves Maintenance Combo for Small Cell Lung Cancer

October 3, 2025

FDA Approves Lurbinectedin Combo for ES-SCLC Maintenance

October 3, 2025

Benefit of Dual Antiplatelet Therapy Murky in Valve-in-Valve Intervention

October 3, 2025
Load More

Categories

Archives

October 2025
MTWTFSS
 12345
6789101112
13141516171819
20212223242526
2728293031 
« Sep    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version